156 related articles for article (PubMed ID: 8215267)
1. Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients.
Gómez-Jiménez J; Ribera E; Gasser I; Artaza MA; Del Valle O; Pahissa A; Martínez-Vázquez JM
Antimicrob Agents Chemother; 1993 Aug; 37(8):1587-92. PubMed ID: 8215267
[TBL] [Abstract][Full Text] [Related]
2. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
Tuncer I; Topcu N; Durmus A; Turkdogan MK
Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
[TBL] [Abstract][Full Text] [Related]
3. Five days of ceftriaxone to treat culture negative neutrocytic ascites in cirrhotic patients.
Baskol M; Gursoy S; Baskol G; Ozbakir O; Guven K; Yucesoy M
J Clin Gastroenterol; 2003; 37(5):403-5. PubMed ID: 14564189
[TBL] [Abstract][Full Text] [Related]
4. Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients.
França A; Giordano HM; Sevá-Pereira T; Soares EC
J Gastroenterol; 2002; 37(2):119-22. PubMed ID: 11871762
[TBL] [Abstract][Full Text] [Related]
5. Short-course ceftriaxone therapy in spontaneous bacterial peritonitis.
Javid G; Khan BA; Khan BA; Shah AH; Gulzar GM; Khan MA
Postgrad Med J; 1998 Oct; 74(876):592-5. PubMed ID: 10211351
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone.
França AV; De Souza JB; Silva CM; Soares EC
J Clin Gastroenterol; 2001 Oct; 33(4):295-8. PubMed ID: 11588542
[TBL] [Abstract][Full Text] [Related]
7. Bacterial profile, drug resistance pattern, clinical and laboratory predictors of ascites infection in cirrhosis patients.
Helil AS; Haile SA; Birhanu Y; Desalegn H; Desalegn DM; Geremew RA; Gebreyohannes Z; Mohammed A; Wondimagegnehu DD; Ayana G; Tizazu AM; Desta K
BMC Infect Dis; 2024 May; 24(1):528. PubMed ID: 38797850
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary and tonsillar distribution of ceftriaxone and cefonicid and the resultant bactericidal activity of the organ].
Fraschini F; Scaglione F
Recenti Prog Med; 1990 Jan; 81(1):41-6. PubMed ID: 2236826
[TBL] [Abstract][Full Text] [Related]
9. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear count response and short-term prognosis.
Mesquita MA; Balbino EP; Albuquerque RS; Carmona CA; Okubo BT; Lorena SL; Montes CG; Soares EC
Hepatogastroenterology; 1997; 44(17):1276-80. PubMed ID: 9356840
[TBL] [Abstract][Full Text] [Related]
11. Modulation of inflammatory response in a cirrhotic rat model with induced bacterial peritonitis.
Sánchez E; Francés R; Soriano G; Mirelis B; Sancho FJ; González-Navajas JM; Muñoz C; Song XY; Pérez-Mateo M; Such J; Guarner C
PLoS One; 2013; 8(3):e59692. PubMed ID: 23527251
[TBL] [Abstract][Full Text] [Related]
12. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
13. Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis.
Li YT; Huang JR; Peng ML
Biomed Res Int; 2020; 2020():3743962. PubMed ID: 32724800
[TBL] [Abstract][Full Text] [Related]
14. The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
Yang L; Gong N; Zhou H; Jiang J
Clin Nephrol; 2019 Jul; 92(1):44-51. PubMed ID: 31131821
[TBL] [Abstract][Full Text] [Related]
15. [Spontaneous bacterial peritonitis].
Skladaný Ľ; Kasová S; Purgelová A; Bystrianska N; Adamcová-Selčanová S
Klin Mikrobiol Infekc Lek; 2016 Dec; 22(4):136-140. PubMed ID: 28147426
[TBL] [Abstract][Full Text] [Related]
16. Changes in the patterns and microbiology of spontaneous bacterial peritonitis : analysis of 200 cirrhotic patients.
Al-Ghamdi H; Al-Harbi N; Mokhtar H; Daffallah M; Memon Y; Aljumah AA; Sanai FM
Acta Gastroenterol Belg; 2019; 82(2):261-266. PubMed ID: 31314186
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous bacterial peritonitis: recent data on incidence and treatment.
Parsi MA; Atreja A; Zein NN
Cleve Clin J Med; 2004 Jul; 71(7):569-76. PubMed ID: 15320366
[TBL] [Abstract][Full Text] [Related]
18. [Incidence of spontaneous bacterial peritonitis in cirrhotic patients with ascites. A two-year prospective study].
Osztrogonácz H; Horváth G; Tolvaj G; Machó M; Bauer E; Dávid K
Orv Hetil; 1996 Jan; 137(4):179-82. PubMed ID: 8721832
[TBL] [Abstract][Full Text] [Related]
19. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
McCabe RE; Schlossberg D; Donowitz GR; Scheld WM; Zellner SR; Lindenberg LB; Armstrong JH; Ein ME
Clin Ther; 1989; 11(3):304-14. PubMed ID: 2663160
[TBL] [Abstract][Full Text] [Related]
20. Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
Ardolino E; Wang SS; Patwardhan VR
Dig Dis Sci; 2019 Aug; 64(8):2359-2367. PubMed ID: 30761472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
